Correction to: Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review

Saeko Fujiwara; Akimitsu Miyauchi; Etsuro Hamaya; Rebecca Jayne Nicholls; Adele Weston; Santwona Baidya; Lionel Pinto; Rich Barron; Junichi Takada

doi:10.1007/s11657-018-0460-6

Correction to: Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review

Arch Osteoporos. 2018 May 8;13(1):58. doi: 10.1007/s11657-018-0460-6.

Authors

Saeko Fujiwara¹, Akimitsu Miyauchi², Etsuro Hamaya³, Rebecca Jayne Nicholls⁴, Adele Weston⁵, Santwona Baidya⁵, Lionel Pinto⁶, Rich Barron⁶, Junichi Takada⁷

Affiliations

¹ Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan.
² Miyauchi Medical Center, JR Takatsuki station NK building 2F, 1-1-1 Akutagawa-cho, Takatsuki-shi, Osaka, 569-1123, Japan. [email protected].
³ Amgen Astellas BioPharma K.K, Tokyo, Japan.
⁴ Real World Evidence Asia Pacific, Mapi, Lyon, France.
⁵ HEOR Asia Pacific Optum, Sydney, Australia.
⁶ Amgen Inc., Thousand Oaks, CA, USA.
⁷ Kitago Orthopedic Clinic, Hokkaido, Japan.

PMID: 29744677
DOI: 10.1007/s11657-018-0460-6

Abstract

In this article it was mistakenly stated that Akimitsu Miyauchi is affiliated with both Miyauchi Medical Center, Osaka and Amgen Astellas BioPharma K.K., Tokyo. In fact he is affiliated only with Miyauchi Medical Center; he has no connection with Amgen Astellas.

Publication types

Published Erratum